Skip to main content

ADVERTISEMENT

Myeloproliferative Neoplasms

qq
Test Your Knowledge
11/11/2021
Which of the following mutations was identified as a high-risk bleeding factor in MPN?
Which of the following mutations was identified as a high-risk bleeding factor in MPN?
Which of the following mutations...
11/11/2021
Oncology
Videos
12/15/2019
Dr Zeidan discusses results from a study of azacitidine plus durvalumab in older patients with AML and high-risk MDS unfit for intensive chemo.
Dr Zeidan discusses results from a study of azacitidine plus durvalumab in older patients with AML and high-risk MDS unfit for intensive chemo.
Dr Zeidan discusses results from...
12/15/2019
Oncology